Search

Search Funnelback University

Search powered by Funnelback
1 - 10 of 10 search results for `treatment for systemic lupus erythematosus`
  1. Fully-matching results

  2. https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/4345

    https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/4345
  3. Human antibody approved for treatment of lupus - MRC Laboratory of…

    https://www2.mrc-lmb.cam.ac.uk/human-antibody-approved-for-treatment-of-lupus/
    Thumbnail for Human antibody approved for treatment of lupus - MRC Laboratory of Molecular Biology 11 Mar 2011: Published on. 11 March, 2011. Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease that can cause debilitating fatigue, painful and swollen joints, fever, skin rash, and kidney problems. ... Food and Drug
  4. LMB News - Page 78 of 83 - MRC Laboratory of Molecular Biology

    https://www2.mrc-lmb.cam.ac.uk/news-events/lmb-news/page/78/
    Thumbnail for LMB News - Page 78 of 83 - MRC Laboratory of Molecular Biology for treatment of lupus. ... Published on. 11 March, 2011. Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease that can cause debilitating fatigue, painful and swollen joints, fever, skin rash, and kidney problems.
  5. https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/4517

    https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/posts/4517
    approved-for-treatment-of-lupus/","title":{"rendered":"Human antibody approved for treatment of lupus"},"content":{"rendered":". Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease that can cause debilitating
  6. https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/pages/4193

    https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/pages/4193
    {"id":4193,"date":"2013-01-07T13:50:34","date_gmt":"2013-01-07T13:50:34","guid":{"rendered":"http://www2.mrc-lmb.cam.ac.uk/wordpress/research/technology-transfer/history-of-technology-transfer/"},"modified":"2023-07-21T12:49:41","modified_gmt":"2023-
  7. Professor David Jayne - Experimental Medicine and Immunotherapeutics…

    https://emit.medschl.cam.ac.uk/people/investigators/dr-david-jayne/
    23 Feb 2024: Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. ... Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
  8. Dr David Jayne | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/jayne
    23 Feb 2024: Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipidsyndrome: A systematic review.
  9. Dr Frances Hall | Sidney Sussex College Cambridge

    https://www.sid.cam.ac.uk/people/dr-frances-hall
    Thumbnail for Dr Frances Hall | Sidney Sussex College Cambridge Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... An audit of recording cardiovascular risk factors in patients with rheumatoid arthritis and systemic lupus erythematosus in
  10. Human Antibodies developed for Treatment of Lupus and Anthrax - MRC…

    https://www2.mrc-lmb.cam.ac.uk/human-antibodies-developed-for-treatment-of-lupus-and-anthrax/
    Thumbnail for Human Antibodies developed for Treatment of Lupus and Anthrax - MRC Laboratory of Molecular Biology 31 Jul 2009: The drug candidates—belimumab (BENLYSTATM, formerly LumphoStat-B), developed by Human Genome Sciences with GlaxoSmithKine as a treatment for systemic lupus erythematosus and raxibacumab (ABthrax), developed by Human Genome Sciences as ... Systemic
  11. History Of Technology Transfer - MRC Laboratory of Molecular Biology

    https://www2.mrc-lmb.cam.ac.uk/research/technology-transfer/history-of-technology-transfer/
    Thumbnail for History Of Technology Transfer - MRC Laboratory of Molecular Biology 21 Jul 2023: This antibody, for treatment of rheumatoid arthritis, proved a blockbuster drug with total sales of more than $10 billion by the end of 2009. ... Other antibodies followed, including BENLYSTA, which promises to be the first new drug treatment for

Refine your results

Related searches for `treatment for systemic lupus erythematosus`

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.